The therapeutic potential of robust cGAS-Stimulator of Interferon Genes (STING) pathway activation in GBM has been demonstrated by the use of synthetic cGAMP as a STING agonist that promotes anti-tumor immunity, implicating both T cells and innate immune cells such as macrophages [120]. This evidence concerns the gene STING1 and neoplasm.